Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Gossamer Bio Inc (GOSS)
NASDAQ:GOSS
Gossamer Bio (GOSS) Stock Price & Analysis
380 Followers
GOSS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.91 - $15.20
Previous Close$1.21
Volume5.41M
Average Volume (3M)2.99M
Market Cap
$116.44M
Enterprise Value-$61.94M
Total Cash (Recent Filing)$201.86M
Total Debt (Recent Filing)$23.48M
Price to Earnings (P/E)-0.5
Beta1.25
Next Earnings
Aug 09, 2023EPS Estimate
-$0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.50
Shares Outstanding95,444,095
10 Day Avg. Volume1,885,949
30 Day Avg. Volume2,989,853
Standard Deviation0.20
R-Squared0.10
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-4.39
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.30
Forecast
1Y Price Target
$4.70Price Target Upside288.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Gossamer Bio News
Pre-EarningsGOSS Upcoming Earnings Report: What to Expect?
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GOSS FAQ
What was Gossamer Bio Inc’s price range in the past 12 months?
Gossamer Bio Inc lowest stock price was $0.91 and its highest was $15.20 in the past 12 months.
What is Gossamer Bio Inc’s market cap?
Currently, no data Available
When is Gossamer Bio Inc’s upcoming earnings report date?
Gossamer Bio Inc’s upcoming earnings report date is Aug 09, 2023 which is in 62 days.
How were Gossamer Bio Inc’s earnings last quarter?
Gossamer Bio Inc released its earnings results on May 09, 2023. The company reported -$0.52 earnings per share for the quarter, beating the consensus estimate of -$0.53 by $0.01.
Is Gossamer Bio Inc overvalued?
According to Wall Street analysts Gossamer Bio Inc’s price is currently Undervalued.
Does Gossamer Bio Inc pay dividends?
Gossamer Bio Inc does not currently pay dividends.
What is Gossamer Bio Inc’s EPS estimate?
Gossamer Bio Inc’s EPS estimate is -$0.5.
How many shares outstanding does Gossamer Bio Inc have?
Gossamer Bio Inc has 95,444,090 shares outstanding.
What happened to Gossamer Bio Inc’s price movement after its last earnings report?
Gossamer Bio Inc reported an EPS of -$0.52 in its last earnings report, beating expectations of -$0.53. Following the earnings report the stock price went up 3.676%.
Which hedge fund is a major shareholder of Gossamer Bio Inc?
Among the largest hedge funds holding Gossamer Bio Inc’s share is Platinum Investment Management. It holds Gossamer Bio Inc’s shares valued at 3M.
---
Gossamer Bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.70 (288.43% Upside)
$4.70 (288.43% Upside)
Blogger Sentiment
Bullish
GOSS Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 2.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.02%
12-Months-Change
Fundamentals
Return on Equity
-9999.00%
Trailing 12-Months
Asset Growth
-25.37%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Gossamer Bio Inc
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate is GB001, which is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.
---
Top 5 ETFs holding GOSS
iShares Biotechnology ETF
$672.62K
Vanguard Health Care ETF
$269.92K
iShares Core S&P Total U.S. Stock Market ETF
$89.20K
iShares NASDAQ US Biotechnology UCITS ETF
$56.64K
iShares Russell 3000 ETF
$16.42K
Up to five ETFs with an Outperform Smart Score that hold GOSS. The ETFs are listed according to market value of GOSS within the ETF
---
---